Slide 1: Uscom Limited FY 2015 Half Yearly Results
Uscom Limited (ASX -‐ UCM) FY 2015 Half Yearly Results For personal use only Thursday 26 January 2015 Premium Cardiovascular Medical Devices Saving lives and Improving care Dr Rob Phillips PhD(Med), MPhil(Med), FASE, DMU(Cardiol) 1 ExecuHve Chairman, Chief ExecuHve Officer, Head Clinical Science www.
Slide 2: Call In Briefing Details
2015 Half Year Results For personal use only Call In Briefing Details 12pm. AEDT, Thursday, 26th February, 2015 Accessing via Telephone: Please dial in five minutes prior to the start of the call and provide the pin number 3175198. Regional dial- in numbers are as follows: ︎ Sydney: 02 9007 4041 ︎ M
Slide 3: Disclaimer
2015 Half Year Results Disclaimer For personal use only This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter. The information in this presentation, whether written or verbal, has been prepared without taking into accou
Slide 4: 2015 Half Year Results agenda
2015 Half Year Results For personal use only • Results • Summary • Financials – year on year, and 3yr growth • Operations – distribution growth • Investment growth • Future growth – strategies and prospects • Questions 4 www.uscom.com.au
Slide 5: Results - Summary
Results - Summary For personal use only Half Year FY 2015 • Revenue up 147% to $0.96m from $0.39m • Sales up 125% to $0.84m from $0.37m • Net loss down 40% to $0.39m from $0.65m • Cash on hand $1m 31 December 2014 • Approaching profitability 5 www.uscom.com.au
Slide 6: Financial Growth H1 2015
Financial Growth For personal use only Growth H1 2015 1200000 +147% 1000000 +125% 956886 +121% 835449 800000 722481 600000 2013 H1 2014 H1 371808 387119 400000 327109 200000 0 Receipts Sales Revenue Revenue year on year 6 www.uscom.com.au
Slide 7: Financial: Quarterly Sales Revenue and Receipts
Financial Growth For personal use only Quarterly Sales Revenue Quarterly Receipts 600000 500000 450000 500000 400000 400000 350000 300000 $ 300000 $ 250000 200000 200000 150000 100000 100000 50000 0 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2013 2013 2013 2013 2014 2014 2014 2014
Slide 8: Operations - Milestones
Operations - Milestones For personal use only Half Year FY 2015 • Chinese FDA registration for the USCOM 1A • Distributors increased by 30% (27 to 35) • New management appointments - distribution + sales • First commercial BP+ manufacture • Johnson & Johnson AusBiotech Company of the Year • USCOM so
Slide 9: Operations - Distribution Agreements
Operations - Growth For personal use only Distribution Agreements 40 35 35 30 +30% 27 25 +125% 20 15 12 10 5 * FY to date 0 2013 2014 2015* Growing distribution, grows revenue 9 www.uscom.com.au
Slide 10: Investment - Uscom Share Price
Investment – Growth For personal use only Uscom Share Price 25 22 20 15 15 $ x 100 10.5 10 6.7 5 0 Jan-12 2012 vwap 2013 vwap 2014 vwap Future driven by; China FDA approval – future revenue growth Impact of BP+ acquisition and marketing Increasing sales and operational strength 10 www.uscom.com.au
Slide 11: Future: Poised for growth
Future Growth For personal use only Poised for growth • Chinese FDA Uscom BP+ registration and revenue • New distributors achieve aggressive revenue targets • Volume manufacture led by demand • New partnerships with distributors of scale and reach • Incremental strategic growth opportunities • Profi
Slide 12: Thank You, Questions and Discussion
Uscom Limited (ASX -‐ UCM) FY 2015 Half Yearly Results For personal use only Thursday 26 January 2015 Thank You Questions and Discussion Dr Rob Phillips PhD(Med), MPhil(Med), FASE, DMU(Cardiol) ExecuHve Chairman, Chief ExecuHve Officer, Head Clinical Science www.uscom.com.au The Measure of Life